Research protocol: Cisplatin-associated ototoxicity amongst patients receiving cancer chemotherapy and the feasibility of an audiological monitoring program

BACKGROUND: Cisplatin is an anti-cancer chemotherapy drug classified as an alkylating agent. It is used for the treatment of a variety of cancers such as cervical, breast, stomach, prostate, bladder and oesophageal, to name a few. However due to its expansive toxicity profile, patients receiving cis...

Descripción completa

Detalles Bibliográficos
Autores principales: Paken, J., Govender, C. D., Sewram, V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725900/
https://www.ncbi.nlm.nih.gov/pubmed/29228931
http://dx.doi.org/10.1186/s12905-017-0486-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725900/
https://www.ncbi.nlm.nih.gov/pubmed/29228931
http://dx.doi.org/10.1186/s12905-017-0486-8

Ejemplares similares